[go: up one dir, main page]

BG108245A - Compositions containing imidazotriazinone for nasal application - Google Patents

Compositions containing imidazotriazinone for nasal application

Info

Publication number
BG108245A
BG108245A BG108245A BG10824503A BG108245A BG 108245 A BG108245 A BG 108245A BG 108245 A BG108245 A BG 108245A BG 10824503 A BG10824503 A BG 10824503A BG 108245 A BG108245 A BG 108245A
Authority
BG
Bulgaria
Prior art keywords
imidazotriazinone
compositions containing
nasal application
nasal
application
Prior art date
Application number
BG108245A
Other languages
Bulgarian (bg)
English (en)
Inventor
Peter Serno
Andreas Ohm
Wolfgang Barth
Richard-Josef Bauer
Hans-Martin Siefert
Dieter Zimmer
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG108245A publication Critical patent/BG108245A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG108245A 2001-04-12 2003-10-09 Compositions containing imidazotriazinone for nasal application BG108245A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10118306A DE10118306A1 (de) 2001-04-12 2001-04-12 Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation

Publications (1)

Publication Number Publication Date
BG108245A true BG108245A (en) 2005-01-31

Family

ID=7681379

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108245A BG108245A (en) 2001-04-12 2003-10-09 Compositions containing imidazotriazinone for nasal application

Country Status (25)

Country Link
US (2) US6740306B2 (xx)
EP (1) EP1381368A2 (xx)
JP (1) JP2004525968A (xx)
KR (1) KR20030087072A (xx)
CN (1) CN1537004A (xx)
AR (1) AR035821A1 (xx)
BG (1) BG108245A (xx)
BR (1) BR0208813A (xx)
CA (1) CA2443639A1 (xx)
CZ (1) CZ20032752A3 (xx)
DE (1) DE10118306A1 (xx)
DO (1) DOP2002000373A (xx)
EC (1) ECSP034795A (xx)
EE (1) EE200300501A (xx)
GT (1) GT200200070A (xx)
HU (1) HUP0303877A3 (xx)
IL (1) IL158255A0 (xx)
MX (1) MXPA03009314A (xx)
NO (1) NO20034556L (xx)
PE (1) PE20021035A1 (xx)
PL (1) PL363033A1 (xx)
RU (1) RU2003133143A (xx)
SK (1) SK12682003A3 (xx)
UY (1) UY27256A1 (xx)
WO (1) WO2002083674A2 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE348618T1 (de) * 2001-05-09 2007-01-15 Bayer Healthcare Ag Neue verwendung von 2-(2-ethoxy-5-(4-methyl- piperazin-1-sulfonyl)-phenyl)-5-methyl-7-propyl 3h-imidazo(5,1-f)(1,2,4)triazin-4-on
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
CN101083984B (zh) * 2004-12-23 2010-11-10 罗克斯罗制药公司 用于经鼻内投与酮咯酸（ketorolac）的治疗组合物
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
JP2008546786A (ja) * 2005-06-23 2008-12-25 シェーリング コーポレイション Ｐｄｅ５インヒビターの迅速吸収性経口処方物
CA2623657A1 (en) * 2005-09-29 2007-04-12 Bayer Healthcare Ag Pde inhibitors and combinations thereof for the treatment of urological disorders
WO2008151734A1 (en) * 2007-06-13 2008-12-18 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
JP2011524366A (ja) * 2008-06-13 2011-09-01 ロクスロ・ファーマ・インコーポレイテッド 鼻内投与のためのケトロラクの薬学的処方物
US8551454B2 (en) * 2009-03-13 2013-10-08 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
US8277781B2 (en) * 2009-03-13 2012-10-02 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
WO2020006606A1 (en) * 2018-07-05 2020-01-09 Helium 3 Resources Pty Ltd A pharmaceutical composition and method of use of same
SE542968C2 (en) * 2018-10-26 2020-09-22 Lindahl Anders Treatment of osteoarthritis
CA3179630A1 (en) * 2020-05-26 2021-12-02 Moses CHOW Formulations and methods for treating erectile dysfunction

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602099A (en) * 1973-04-02 1986-07-22 Merrell Dow Pharmaceuticals Inc. Antirhinovirus agents
GB9013750D0 (en) 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9514465D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
GB9514473D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
WO1997045427A1 (fr) 1996-05-31 1997-12-04 Mochida Pharmaceutical Co., Ltd. DERIVES DE PYRIDOCARBAZOLE AYANT UN EFFET INHIBITEUR DE cGMP-PDE
GB2315673A (en) * 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
CA2291256A1 (en) * 1997-05-29 1998-12-03 Mochida Pharmaceutical Co., Ltd. Therapeutic agent for erection dysfunction
JP2001517628A (ja) 1997-09-23 2001-10-09 イーライ・リリー・アンド・カンパニー 注意欠陥／多動障害の治療法
AU738675B2 (en) 1997-11-12 2001-09-20 Bayer Intellectual Property Gmbh 2-phenyl-substituted imidazotriazinones as phosphodiesterase inhibitors
TWI223598B (en) * 1998-06-22 2004-11-11 Pfizer Ireland Pharmaceuticals An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
AU4717299A (en) * 1998-06-26 2000-01-17 Nastech Pharmaceutical Company, Inc Nasal delivery of sildenafil citrate
CN1526448A (zh) * 1998-12-14 2004-09-08 ���ռ�ҩ��ɷ����޹�˾ 用于治疗肛门直肠病的药物和方法

Also Published As

Publication number Publication date
HUP0303877A2 (hu) 2004-03-29
NO20034556L (no) 2003-12-10
PE20021035A1 (es) 2002-11-29
GT200200070A (es) 2003-01-31
KR20030087072A (ko) 2003-11-12
ECSP034795A (es) 2003-12-01
EP1381368A2 (de) 2004-01-21
AR035821A1 (es) 2004-07-14
PL363033A1 (en) 2004-11-15
CA2443639A1 (en) 2002-10-24
MXPA03009314A (es) 2004-03-10
WO2002083674A2 (de) 2002-10-24
DOP2002000373A (es) 2002-11-30
CN1537004A (zh) 2004-10-13
WO2002083674A3 (de) 2003-01-09
BR0208813A (pt) 2004-03-09
HUP0303877A3 (en) 2005-05-30
EE200300501A (et) 2003-12-15
SK12682003A3 (sk) 2004-03-02
JP2004525968A (ja) 2004-08-26
IL158255A0 (en) 2004-05-12
RU2003133143A (ru) 2005-04-10
US20030022894A1 (en) 2003-01-30
DE10118306A1 (de) 2002-10-17
US20040248891A1 (en) 2004-12-09
UY27256A1 (es) 2002-11-29
NO20034556D0 (no) 2003-10-10
CZ20032752A3 (cs) 2004-01-14
US6740306B2 (en) 2004-05-25

Similar Documents

Publication Publication Date Title
MXPA03009314A (es) Composiciones que contienen imidazotriazinona para administracion nasal.
AP2001002204A0 (en) Pyrazole derivatives.
TW200518771A (en) Formulations for coated microprojections containing non-volatile counterions
PL361404A1 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
MXPA02012033A (es) Derivados de 2-aminocarbonil-9h-purina.
TNSN04141A1 (en) NEW COMPOUNDS - DDP - IV difluor
HUP0303886A3 (en) New film coating composition for coating of pharmaceutical compositions
AU2003228770A8 (en) Substituted pyrazolopyrimidines
TNSN07235A1 (en) Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
MY126917A (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
IL160769A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL163777A0 (en) Kinase inhibitors
PT1448853E (pt) Melhoramentos relacionados com branqueadores ópticos
UA96759C2 (xx) ПОХІДНІ 2-АРИЛІНДОЛУ ЯК mPGES-1 ІНГІБІТОРИ$ПРОИЗВОДНЫЕ 2-АРИЛИНДОЛА КАК mPGES-1 ИНГИБИТОРЫ
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
MXPA04006266A (es) Pirimidotriazinas como inhibidores de fosfatasa.
IL160819A0 (en) Novel compounds and compositions as cathepsin inhibitors
MXPA04003755A (es) Endoprotesis vasculares.
AU2002343661A1 (en) Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the teatment of cancer
CO5580729A2 (es) Composiciones nutricionales que comprenden cistationina
WO2003022844A3 (en) Synthesis of epothilones intermediates thereto and analogues thereof
DE60201074D1 (en) Pyrazolopyridinderivate
WO2002083108A3 (de) Zusammensetzungen enthaltend cgmp-pde-inhibitoren und lokalanästhetika zur nasalen applikation